ABOUT THE PRESENTATION
Although cardiac diseases are common in cats and dogs, it can be challenging to diagnose, monitor, and predict outcomes in these cases. As a result, many different methods are often employed to assess the cardiac status of a patient, including auscultation, radiography, blood pressure, and echocardiography. It was 10 years ago that a new cardiac biomarker, NT-proBNP (N-terminal pro B-type natriuretic peptide),  was introduced to veterinary medicine. As with any new tool, it has  taken time to understand the benefits and limitations of this test for assessing cardiac health.

ABOUT THE PRESENTER
Rick Hartigan, DVM, Professional Services Veterinarian, IDEXX

Dr. Hartigan received his DVM degree from the Purdue University College of Veterinary Medicine. His professional experience includes working as an associate veterinarian in practices in Indiana and Virginia, owning a practice in Virginia for 20 years and working as medical director of a large corporate-owned animal hospital in Virginia. He has served on the Board of Directors and as President of the Virginia Veterinary Medical Association.  Dr. Hartigan’s emphasis at IDEXX is in companion animal diagnostics and medicine. He supports the Capitol Region, working with the IDEXX team in Virginia, Maryland, Washington, D.C. and Delaware through medical consultations with practitioners and with continuing education presentations for veterinary medical associations and practitioner groups including current information from leading researchers and veterinary specialists on canine and feline diagnostics and medicine topics.

Special Thanks to IDEXX for sponsoring this event!